Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Tinea capitis needs systemic treatment to avoid severe outcomes.

Demodex folliculitis can occur in HIV patients on HAART, and treatment may involve topical creams or medication changes.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

A woman with a rare form of multiple myeloma had a headache and a skull mass, which led to her diagnosis after tests and a biopsy.

Two Hispanic women developed Plica neuropathica, a condition causing tangled hair, possibly due to hair damage and various risk factors.

Botulinum toxin A may be an effective alternative treatment for the scalp disorder folliculitis decalvans.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Lithium can cause skin changes similar to mycosis fungoides.

Early diagnosis and treatment of favus can prevent permanent hair loss.

TGF-β and TNF influence hair follicle cell fate, with TNF being more effective in triggering cell death.

The man's rash, hair loss, and vision issues were due to syphilis, not CMV.

FFA and FAPD might be related or stages of the same disease.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.

Dermoscopic and histopathological features combined can help diagnose Pityriasis versicolor.

Two women lost hair after mesotherapy for hair loss, with one having permanent and the other temporary hair loss.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Cyclosporin A promotes hair cell growth and affects protein kinase C levels.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Topical oligonucleotide therapy targets hair follicles effectively.

The hair disorder was caused by abnormal protein formation, making hair easily damaged.

Isotretinoin and other medications showed promising results for treating a rare scalp condition linked to severe acne.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.